Castle Biosciences Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Castle Biosciences Inc. (CSTL) IPO Opens 25% Higher
July 25, 2019 12:19 PM EDTToday's IPO for Castle Biosciences Inc. (NASDAQ: CSTL) opened for trading at $20 after pricing 4,000,000 shares of its common stock at a price to the public of $16.00 per share.
In addition, Castle Biosciences has granted the underwriters a 30-day option to purchase up to... More



